On 24 February AmCham EU hosted an event focusing on the future of risk management in the EU chemicals policy. The speakers discussed the principles of risk assessment and the importance of a science-based approach in a panel moderated by Natasa Sbrizaj (3M), Chair, Environment Committee, AmCham EU. More about AmCham EU's position on the EU's Chemicals Strategy for Sustainability here.
The future of risk management and risk assessment in EU chemicals policy
On 24 February AmCham EU hosted an event focusing on the future of risk management in the EU chemicals policy. The speakers discussed the principles of risk assessment and the importance of a science-based approach in a panel moderated by Natasa Sbrizaj (3M), Chair, Environment Committee, AmCham EU. More about AmCham EU's position on the EU's Chemicals Strategy for Sustainability here.
Below find the names of the speakers:
Matthias Herzler, Head of Unit for Coordination and Overall Assessment, German Federal Institute for Risk Assessment
Otto Linher, Senior Expert, REACH Unit, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Alexander Majer, Deputy Head of European Regulatory Affairs and Government Relations, First Solar
Kristin Schreiber, Director, Ecosystems I: Chemicals, Food and Retail, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Marko Susnik, Advisor to the Secretary-General on Chemicals, SMEunited and Senior Advisor, Chemicals, Austrian Federal Economic Chamber
Related items
:focal())
Position Paper
13 May 2026
Strengthening Europe’s cybersecurity framework through simplification
The review of the Cybersecurity Act (CSA 2.0) is an opportunity to build a more coherent, outcome-oriented EU cybersecurity framework. While the proposal recognises fragmentation across the Single Market, further simplification is needed to reduce overlaps and support effective compliance.
A harmonised approach to risk assessment and supervision can strengthen resilience while avoiding duplicative obligations. Certification and supply-chain measures should remain risk-based, objective, technical and aligned with international standards. Structured industry engagement and clear designation thresholds under the ICT Supply Chain Framework and a secure-by-design approach to policymaking will be essential to support cybersecurity and global interoperability. Read more on how CSA 2.0 can strengthen resilience across the Single Market.
:focal())
News
4 May 2026
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
News
4 May 2026
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.